Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,778 public trials 699 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Safety and Efficacy of RAD001 in Participants With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy

NCT00702052

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Mayo Clinic - Arizona Mayo Clinic - Scottsdale Multiple Locations, Arizona, United States
  • Highlands Oncology Group DeptofHighlandsOncologyGrp(2) Fayetteville, Arkansas, United States
  • Bay Area Cancer Research Dept.ofBayAreaCancerResearch Concord, California, United States
  • City of Hope National Medical Center Dept.ofCityofHopeMedicalCtr(1) Duarte, California, United States
View all 31 locations
View Trial Details
Completed

A Study of Atezolizumab in Combination With Either Obinutuzumab Plus Bendamustine or Obinutuzumab Plus (+) Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Participants With Follicular Lymphoma (FL) or Rituximab + CHOP in Participants With Diffuse Large B-Cell Lymphoma (DLBCL)

NCT02596971

Conditions
Diffuse Large B-Cell Lymphoma, Lymphoma Follicular, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Rocky Mountain Cancer Center - Aurora Aurora, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • University Miami Miami, Florida, United States
  • New York Uni Medical Center New York, United States
View all 21 locations
View Trial Details
Completed

Bendamustine and Rituximab Followed by 90-yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma

NCT01234766

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Maine Center for Cancer Medicine Scarborough, Maine, United States
  • Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Rhode Island Hospital Providence, Rhode Island, United States
View Trial Details
Completed

Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma

NCT00052936

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +27 more
Locations
  • Haematologisch Onkologische Praxis Aachen, Germany
  • Klinikum St. Marien Amberg, Germany
  • Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie Ansbach, Germany
  • II. Medizinische Klinik Aschaffenburg, Germany
View all 174 locations
View Trial Details
Completed

GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (ASSIST_FL)

NCT01419665

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Investigative site La Plata, Argentina
  • Investigative site Rosario, Argentina
  • Investigative site San Miguel de Tucumán, Argentina
  • Investigative site Adelaide, Australia
View all 153 locations
View Trial Details
Completed

Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma

NCT01742988

Conditions
Double-expressor Lymphoma (DEL), Double-hit Lymphoma (DHL), Hemic and Lymphatic Diseases, +18 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • University of Chicago Medicine Chicago, Illinois, United States
View Trial Details

Related conditions